Welcome to our dedicated page for iPath® Series B S&P 500® VIX Mid-Term Futures™ ETN news (Ticker: VXZ), a resource for investors and traders seeking the latest updates and insights on iPath® Series B S&P 500® VIX Mid-Term Futures™ ETN stock.
The news feed for the iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ)Barclays Bank PLC. Barclays’ recent announcements focus on cash tender offers, consent solicitations, and issuer redemptions for various iPath ETN series, illustrating the types of corporate actions that can affect ETN holders. These communications describe how Barclays may seek consents from noteholders to amend note provisions, determine purchase prices for tendered notes, and, in some cases, redeem entire ETN series after amendments take effect.
Barclays’ releases also emphasize the risk profile of its ETNs. They highlight that iPath ETNs are unsecured debt obligations of Barclays Bank PLC, that investors may lose some or all of their principal, and that the market value of ETNs can be influenced by many unpredictable factors. The announcements repeatedly note that the ETNs are not obligations of or guaranteed by any third party and that the actual and perceived creditworthiness of Barclays can affect ETN pricing before maturity or redemption.
News items from Barclays describe extensions and amendments to tender offers, changes to purchase prices per note, and the number of notes tendered in specific offers. They also point investors to the Offer to Purchase and Consent Solicitation Statement and its supplements for full terms and conditions. While the specific series named in these announcements differ from VXZ, the disclosures provide context on how Barclays manages its ETN lineup and the processes it follows when modifying terms or retiring particular ETN series.
Investors following VXZ-related news can use this page to monitor Barclays’ communications about the iPath ETN platform, including risk disclosures, tender offer activity, and any future actions that may be relevant to VXZ as a member of the iPath ETN family.
Barclays Bank PLC has announced updates to its cash tender offers and consent solicitations for five series of exchange-traded notes (ETNs). The bank has:
- Determined results for one expired series (iPath® Bloomberg Platinum Subindex Total Return℠ ETN)
- Extended the expiration deadline to November 20, 2024, for four other series
- Amended the purchase price for certain extended series
For the expired series, Barclays accepted 40,542 notes at $22.00 per note, totaling $891,924. The settlement date is October 2, 2024. For the extended series, the purchase prices range from $6.00 to $115.00 per note, reflecting a premium to the Closing Indicative Note Value as of September 25, 2024. Barclays may further amend the offers based on changes in the applicable Closing Index Levels.
Barclays Bank PLC has amended the Purchase Price for certain series of its outstanding exchange-traded notes (ETNs) in its ongoing cash tender offers and consent solicitations. The amended prices apply to the iPath® CBOE S&P 500 BuyWrite IndexSM ETN (BWVTF) and iPath® Bloomberg Platinum Subindex Total ReturnSM ETN (PGMFF). The new Purchase Prices reflect a premium to the Closing Indicative Note Value as of September 10, 2024.
Key points:
- BWVTF: New Purchase Price $115.00 (previous Closing Indicative Value $108.77)
- PGMFF: New Purchase Price $22.00 (previous Closing Indicative Value $18.59)
- Expiration Date remains September 25, 2024
- Payment Date is October 2, 2024, unless extended or terminated early